Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases.
Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.
Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases.
Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases.
